CoChat

Nucleotide excision repair deficiency in melanoma in response to UVA

Open access
Murray, Heather C., Maltby, Vicki E., Smith, Doug W., Bowden, Nikola A. · 2015 · Experimental Hematology & Oncology

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The causative link between UV exposure and melanoma development is well known, however the mechanistic relationship remains incompletely characterised. UVA and UVB components of sunlight are implicated in melanomagenesis; however the majority of studies have focused on the effects of UVB and UVC light. Interestingly, melanoma tumour sequencing has revealed an overrepresentation of mutations signature of unrepaired UV-induced DNA damage. Repair of UVA-induced DNA damage is thought to occur primarily through the Nucleotide Excision Repair (NER) pathway, which recognises and repairs damage either coupled to transcription (Transcription Coupled Repair; TCR), or through global genome scanning (Global Genome Repair; GGR). Current literature suggests NER is deficient in melanoma, however the cause of this remains unknown; and whether reduced NER activity in response to UVA may be involved in melanoma development remains uncharacterised. In this study we aimed to determine if melanoma cells exhibit reduced levels of NER activity in response to UVA. METHODS: Melanocyte and melanoma cell lines were UVA-irradiated, and DNA damage levels assessed by immunodetection of Cyclobutane Pyrimidine Dimer (CPD) and (6-4) Photoproduct [(6-4)PP] lesions. Expression of NER pathway components and p53 following UVA treatment was quantified by qPCR and western blot. RESULTS: UVA did not induce detectable induction of (6-4)PP lesions, consistent with previous studies. Repair of CPDs induced by UVA was initiated at 4 h and complete within 48 h in normal melanocytes, whereas repair initiation was delayed to 24 h and >40 % of lesions remained in melanoma cell lines at 48 h. This was coupled with a delayed and reduced induction of GGR component XPC in melanoma cells, independent of p53. CONCLUSION: These findings support that NER activity is reduced in melanoma cells due to deficient GGR. Further investigation into the role of NER in UVA-induced melanomagenesis is warranted and may have implications for melanoma treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40164-016-0035-4

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Immunodetection of (6-4)PP and CPD induction in response to UVA and UVB. Melanoma (Me4405, Sk-Mel-28) cell lines were irradiated with UVA or UVB, and DNA damage lesions were quantified at 0 h. a (6-4)PP and b CPD quantitation and corresponding raw images. Signal was normalised to cell number; points mean of three independent experiments, bars SEM. Images depict cell stain signal (red, 700 nm channel) overlaid with the DNA damage signal (green, 800 nm channel)
Fig. 1 Immunodetection of (6-4)PP and CPD induction in response to UVA and UVB. Melanoma (Me4405, Sk-Mel-28) cell lines were irradiated with UVA or UVB, and DNA damage lesions were quantified at 0 h. a (6-4)PP and b CPD quantitation and corresponding raw images. Signal was normalised to cell number; points mean of three independent experiments, bars SEM. Images depict cell stain signal (red, 700 nm channel) overlaid with the DNA damage signal (green, 800 nm channel)CC BY · PubMed Central
Fig. 2 CPD repair after UVA in melanocytes and melanoma. Melanocyte (HEMaLP) and melanoma cell lines (MM200, Sk-Mel-28, Me4405, Mel-RM) were irradiated with 100 kJ/m2 UVA, and CPD lesions quantified following irradiation. Results are shown as a percentage of 0 h. Bars mean of four independent experiments ± SEM. Significance determined by Mann–Whitney U test for all melanoma cell lines compared to melanocytes (HEMaLP) *p < 0.01
Fig. 2 CPD repair after UVA in melanocytes and melanoma. Melanocyte (HEMaLP) and melanoma cell lines (MM200, Sk-Mel-28, Me4405, Mel-RM) were irradiated with 100 kJ/m2 UVA, and CPD lesions quantified following irradiation. Results are shown as a percentage of 0 h. Bars mean of four independent experiments ± SEM. Significance determined by Mann–Whitney U test for all melanoma cell lines compared to melanocytes (HEMaLP) *p < 0.01CC BY · PubMed Central
Fig. 3 Expression of global genome repair XPC, DDB1, and DDB2 following UVA irradiation in melanocytes and melanoma. Cell lines were irradiated with 100 kJ/m2 UVA, then mRNA transcript relative expression (RE) at baseline and 1, 4, 24, and 48 h post-irradiation was determined. a RE of XPC mRNA transcript b DDB1 mRNA transcript, c DDB2 mRNA transcript. Significance compared to melanocytes (HEMaLP) determined by Mann–Whitney U test. *p < 0.05. Points mean of triplicate determinations of three independent experiments; bars ± SEM. d Western blot of XPC, DDB1 and DDB2 for all cell lines before and after UVA. Blots are representative of duplicate blots run for all proteins and cell lines
Fig. 3 Expression of global genome repair XPC, DDB1, and DDB2 following UVA irradiation in melanocytes and melanoma. Cell lines were irradiated with 100 kJ/m2 UVA, then mRNA transcript relative expression (RE) at baseline and 1, 4, 24, and 48 h post-irradiation was determined. a RE of XPC mRNA transcript b DDB1 mRNA transcript, c DDB2 mRNA transcript. Significance compared to melanocytes (HEMaLP) determined by Mann–Whitney U test. *p < 0.05. Points mean of triplicate determinations of three independent experiments; bars ± SEM. d Western blot of XPC, DDB1 and DDB2 for all cell lines before and after UVA. Blots are representative of duplicate blots run for all proteins and cell linesCC BY · PubMed Central
Fig. 4 Expression of p53 following UVA irradiation in melanocytes and melanoma. Cell lines were irradiated with 100 kJ/m2 UVA, then mRNA transcript relative expression (RE) at baseline and 1, 4, 24, and 48 h post-irradiation was determined. a RE of p53 mRNA transcript. Significance compared to melanocytes (HEMaLP) determined by Mann–Whitney U test. *p < 0.05. Points mean of triplicate determinations of three independent experiments; bars ± SEM. b Western blot of p53 for all cell lines before and after UVA. Blots are representative of duplicate blots run for all proteins and cell lines
Fig. 4 Expression of p53 following UVA irradiation in melanocytes and melanoma. Cell lines were irradiated with 100 kJ/m2 UVA, then mRNA transcript relative expression (RE) at baseline and 1, 4, 24, and 48 h post-irradiation was determined. a RE of p53 mRNA transcript. Significance compared to melanocytes (HEMaLP) determined by Mann–Whitney U test. *p < 0.05. Points mean of triplicate determinations of three independent experiments; bars ± SEM. b Western blot of p53 for all cell lines before and after UVA. Blots are representative of duplicate blots run for all proteins and cell linesCC BY · PubMed Central
Fig. 5 Relative expression (RE) of GGR transcripts a XPC, b DDB1, and c DDB2 following UVA irradiation in p53- and p53 + melanoma cell lines. p53 mutant/null (p53−; Sk-Mel-28, Me4405) and p53 wildtype (p53+; MM200, Mel-RM melanoma cell lines were irradiated with 100 kJ/m2 UVA, then RE at baseline and 1, 4, 24, and 48 h post-irradiation was determined. Points mean of triplicate determinations of three independent experiments; bars ± SEM. Significant differences between groups were determined by Mann–Whitney U test. *p < 0.05, **p < 0.005, ***p < 0.000
Fig. 5 Relative expression (RE) of GGR transcripts a XPC, b DDB1, and c DDB2 following UVA irradiation in p53- and p53 + melanoma cell lines. p53 mutant/null (p53−; Sk-Mel-28, Me4405) and p53 wildtype (p53+; MM200, Mel-RM melanoma cell lines were irradiated with 100 kJ/m2 UVA, then RE at baseline and 1, 4, 24, and 48 h post-irradiation was determined. Points mean of triplicate determinations of three independent experiments; bars ± SEM. Significant differences between groups were determined by Mann–Whitney U test. *p < 0.05, **p < 0.005, ***p < 0.000CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Research works printed but not linked: 2

  1. Stoyanova T Roy N Kopanja D Bagchi S Raychaudhuri P DDB2 decides cell fate following DNA damage Proc Natl Acad Sci USA 2009 106 26 10690 10695 10.1073/pnas.0812254106 19541625 PMC2705559 · DOI · Paper page
  2. Bowden NA Ashton KA AveryKiejda KA Zhang XD Hersey P Scott RJ Nucleotide excision repair gene expression after cisplation treatment in melanoma Cancer Res. 2010 70 7905 7917 10.1158/0008-5472.CAN-10-0161 20807809 · DOI

Cited by

See all 30

Metadata

Authors
Murray, H. C., Maltby, V. E., Smith, D. W., & Bowden, N. A.
Affiliations
Hunter Medical Research Institute (AU)
Corresponding author
Bowden, Nikola A.
Venue
Experimental Hematology & Oncology
Published
2015-12
Volume
5
Issue
1
Pages
6-6
ISSN
2162-3619 (ISSN-L)
OpenAlex
W2287099773
Cited by
28
References
63
Citations by year
2025: 2 · 2024: 3 · 2023: 2 · 2022: 5 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 2
FWCI
1.30
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Experimental Hematology and Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • NOVA (University of Newcastle Australia) (submittedVersion, cc-by)
Funders
  • Cure Cancer Australia Foundation
  • Cancer Australia
  • National Health and Medical Research Council (AU)
  • Cancer Institute NSW
  • Canadian Institutes of Health Research (CA)
  • Multiple Sclerosis Research Australia (AU)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
nucleotide excision repair, melanoma, UVA, global genome repair, transcription-coupled repair, cyclobutane pyrimidine dimers, 6-4 photoproducts, XPC, p53, UV-induced DNA damage, melanomagenesis, melanocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nucleotide excision repair deficiency in melanoma in response to UVA. https://app.cochat.ai/papers/10.1186/s40164-016-0035-4
The paper
Murray, H. C., Maltby, V. E., Smith, D. W., & Bowden, N. A. (2015). Nucleotide excision repair deficiency in melanoma in response to UVA. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-016-0035-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.